187 related articles for article (PubMed ID: 26813006)
1. Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury.
Wu X; Yin T; Tian J; Tang C; Huang J; Zhao Y; Zhang X; Deng X; Fan Y; Yu D; Wang G
Regen Biomater; 2015 Jun; 2(2):87-96. PubMed ID: 26813006
[TBL] [Abstract][Full Text] [Related]
2. First in vitro and in vivo results of an anti-human CD133-antibody coated coronary stent in the porcine model.
Sedaghat A; Sinning JM; Paul K; Kirfel G; Nickenig G; Werner N
Clin Res Cardiol; 2013 Jun; 102(6):413-25. PubMed ID: 23397592
[TBL] [Abstract][Full Text] [Related]
3. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
[TBL] [Abstract][Full Text] [Related]
4. Study of a novel coating strategy for coronary stents: evaluation of stainless metallic steel coated with VEGF and anti-CD34 antibody in vitro.
Song CL; Li Q; Zhang JC; Wang JP; Xue X; Wang G; Shi YF; Diao HY; Liu B
Eur Rev Med Pharmacol Sci; 2016; 20(2):311-6. PubMed ID: 26875902
[TBL] [Abstract][Full Text] [Related]
5. Hydroxybutyl Chitosan Polymer-Mediated CD133 Antibody Coating of Metallic Stents to Reduce Restenosis in a Porcine Model of Atherosclerosis.
Li J; Zhang Q; Li D; An Y; Kutryk MB
J Cardiovasc Pharmacol Ther; 2015 May; 20(3):322-9. PubMed ID: 25412893
[TBL] [Abstract][Full Text] [Related]
6. Late endothelial progenitor cell-capture stents with CD146 antibody and nanostructure reduce in-stent restenosis and thrombosis.
Park KS; Kang SN; Kim DH; Kim HB; Im KS; Park W; Hong YJ; Han DK; Joung YK
Acta Biomater; 2020 Jul; 111():91-101. PubMed ID: 32434081
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD133 antibody immobilized on the surface of stents enhances endothelialization.
Li J; Li D; Gong F; Jiang S; Yu H; An Y
Biomed Res Int; 2014; 2014():902782. PubMed ID: 24734251
[TBL] [Abstract][Full Text] [Related]
8. Functionalized CD133 antibody coated stent surface simultaneously promotes EPCs adhesion and inhibits smooth muscle cell proliferation-A novel approach to prevent in-stent restenosis.
Wawrzyńska M; Duda M; Wysokińska E; Strządała L; Biały D; Ulatowska-Jarża A; Kałas W; Kraszewski S; Pasławski R; Biernat P; Pasławska U; Zielonka A; Podbielska H; Kopaczyńska M
Colloids Surf B Biointerfaces; 2019 Feb; 174():587-597. PubMed ID: 30504039
[TBL] [Abstract][Full Text] [Related]
9. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization.
Nakazawa G; Granada JF; Alviar CL; Tellez A; Kaluza GL; Guilhermier MY; Parker S; Rowland SM; Kolodgie FD; Leon MB; Virmani R
JACC Cardiovasc Interv; 2010 Jan; 3(1):68-75. PubMed ID: 20129572
[TBL] [Abstract][Full Text] [Related]
11. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation.
Lim WH; Seo WW; Choe W; Kang CK; Park J; Cho HJ; Kyeong S; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2798-805. PubMed ID: 22015656
[TBL] [Abstract][Full Text] [Related]
12. [Stents coated with sirolimus and anti-CD34 antibody can optimize the performance of sirolimus-eluting stents].
Song XT; Zhu HG; Yang XS; Yuan F; Lü SZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Nov; 39(11):997-1004. PubMed ID: 22336451
[TBL] [Abstract][Full Text] [Related]
13. Co-immobilization of CD133 antibodies, vascular endothelial growth factors, and REDV peptide promotes capture, proliferation, and differentiation of endothelial progenitor cells.
Duan Y; Yu S; Xu P; Wang X; Feng X; Mao Z; Gao C
Acta Biomater; 2019 Sep; 96():137-148. PubMed ID: 31284097
[TBL] [Abstract][Full Text] [Related]
14. Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin.
Lee JM; Choe W; Kim BK; Seo WW; Lim WH; Kang CK; Kyeong S; Eom KD; Cho HJ; Kim YC; Hur J; Yang HM; Cho HJ; Lee YS; Kim HS
Biomaterials; 2012 Dec; 33(35):8917-27. PubMed ID: 22981075
[TBL] [Abstract][Full Text] [Related]
15. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
[TBL] [Abstract][Full Text] [Related]
16. The effect of REDV/TiO
Xu X; Wang L; Wang G; Jin Y
J Biomater Appl; 2017 Jan; 31(6):911-922. PubMed ID: 30208804
[TBL] [Abstract][Full Text] [Related]
17. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
[TBL] [Abstract][Full Text] [Related]
18. Construction of biological factor-coated stent and its effect on promoting endothelialization.
Sun A; Huang X; Jiao Y; Wang X; Wen J
Mater Sci Eng C Mater Biol Appl; 2021 Mar; 122():111943. PubMed ID: 33641929
[TBL] [Abstract][Full Text] [Related]
19. Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor.
Ma X; Hibbert B; Dhaliwal B; Seibert T; Chen YX; Zhao X; O'Brien ER
Cardiovasc Res; 2010 May; 86(2):338-45. PubMed ID: 20167573
[TBL] [Abstract][Full Text] [Related]
20. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model.
Larsen K; Cheng C; Tempel D; Parker S; Yazdani S; den Dekker WK; Houtgraaf JH; de Jong R; Swager-ten Hoor S; Ligtenberg E; Hanson SR; Rowland S; Kolodgie F; Serruys PW; Virmani R; Duckers HJ
Eur Heart J; 2012 Jan; 33(1):120-8. PubMed ID: 21733913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
